BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jul 27, 2009
 |  BC Week In Review  |  Company News  |  Deals

SkyePharma, Novartis deal

Novartis returned to SkyePharma all rights to market formoterol delivered using SkyePharma's SkyeHaler dry powder inhaler. Formoterol is a long-acting beta-2

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >